Medpace Holdings Inc
NASDAQ:MEDP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
284.87
457.29
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Medpace Holdings Inc
Wall Street
Price Targets
MEDP Price Targets Summary
Medpace Holdings Inc
According to Wall Street analysts, the average 1-year price target for
MEDP
is 360.77 USD
with a low forecast of 308.05 USD and a high forecast of 420 USD.
MEDP Last Price Targets
Medpace Holdings Inc
The latest public price target was made on Oct 23, 2024 by
Eric Coldwell
from
Robert W. Baird
,
who expects
MEDP
stock to
rise by 3%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Eric Coldwell
Robert W. Baird
|
349
USD
Upside 3% |
2 months ago
Oct 23, 2024
|
Baird Downgrades Medpace (MEDP) to Neutral
StreetInsider
|
David Windley
Jefferies
|
345
USD
Upside 2% |
2 months ago
Sep 25, 2024
|
Medpace downgraded to Hold from Buy at Jefferies
TheFly
|
Jailendra Singh
Truist Financial
|
415
USD
Upside 22% |
4 months ago
Aug 1, 2024
|
Medpace initiated with a Hold at Truist
TheFly
|
|
Eric Coldwell
Robert W. Baird
|
469
USD
Upside 38% |
5 months ago
Jul 8, 2024
|
Medpace (MEDP) PT Raised to $469 at Baird
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
456
USD
Upside 34% |
6 months ago
Jun 13, 2024
|
Medpace (MEDP) PT Raised to $456 at Baird
StreetInsider
|
Ann Hynes
Mizuho Securities
|
435
USD
Upside 28% |
6 months ago
May 28, 2024
|
Mizuho Starts Medpace (MEDP) at Buy
StreetInsider
|
|
David Windley
Jefferies
|
450
USD
Upside 33% |
8 months ago
Apr 23, 2024
|
Jefferies Upgrades Medpace (MEDP) to Buy
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MEDP's stock price target?
Price Target
360.77
USD
According to Wall Street analysts, the average 1-year price target for
MEDP
is 360.77 USD
with a low forecast of 308.05 USD and a high forecast of 420 USD.
What is Medpace Holdings Inc's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Medpace Holdings Inc's revenue is
23%.
The projected
CAGR
for the next 4 years is
11%.
What is Medpace Holdings Inc's Operating Income forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Medpace Holdings Inc's operating income is
35%.
The projected
CAGR
for the next 4 years is
15%.
What is Medpace Holdings Inc's Net Income forecast?
Projected CAGR
16%
The
compound annual growth rate
of Medpace Holdings Inc's net income for the next 4 years is
16%.
You don't have any saved screeners yet
